[ Price : $8.95]
Federal Register notice: FDA establishes a docket to obtain information and comments that will assist it in determining whether to...[ Price : $8.95]
A CDRH Industry Basics webcast gives basic program information on the 513(g) device determination and classification process and t...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Spark Therapeutics Luxturna...[ Price : $8.95]
AdvaMed says that if Congress does not repeal the medical device tax before the end of the year, more than 20,000 industry jobs wi...[ Price : $8.95]
The Medical Information Working Group says FDA should incorporate principles from five recent Supreme Court free speech decisions ...[ Price : $8.95]
Federal Register notice: FDA announces a 12/17 Oncologic Drugs Advisory Committee meeting that with discuss an AstraZeneca supplem...[ Price : $8.95]
The Justice Department says Rising Pharmaceuticals will pay over $3 million to resolve price fixing charges and will cooperate wit...[ Price : $8.95]
FDA approves a Genentech supplemental BLA for Tecentriq (atezolizumab) in combination with chemotherapy for the initial treatment ...